Product Information
MIDAZOLAM HCL 2 MG/2 ML VIAL is a generic product labeled by Almaject, Inc., priced at $0.2400 per ML under NDC 72611074125. Its NADAC has been published 81 times since Sep 18, 2024.
FDA first approved this application on Feb 29, 2012. Its Orange Book therapeutic-equivalence code is AP.
Strength
1 mg/mL
Manufacturer
Almaject, Inc.NDC
72611074125
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
3/18/2026
Active Ingredients
MIDAZOLAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090696FDA Approved
2/29/2012
TE Code
AP
On Market Since
4/14/2020
Pharmacological Classes
Price Statistics
The NADAC for MIDAZOLAM HCL 2 MG/2 ML VIAL has been published 81 times since Sep 18, 2024, and over the history we have for it it has risen 28.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2400 per ML |
|---|---|
| All-time high | $0.2408 (Mar 11, 2026) |
| All-time low | $0.1862 (Sep 18, 2024) |
| 52-week high | $0.2408 |
| 52-week low | $0.2269 |
| Median price | $0.2086 |
| Average price | $0.2135 |
| Largest weekly change | +6.2% (Nov 20, 2024) |
| Weeks tracked | 81 |
| Tracking since | Sep 18, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+5.8%
3Y
N/A
5Y
N/A
All
+28.9%
Last surveyed Apr 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the midazolam market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Almaject, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
midazolam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIDAZOLAM HCL 2 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for MIDAZOLAM HCL 2 MG/2 ML VIAL, manufactured by Almaject, Inc., is $0.2400 per ML (NDC 72611074125), effective Apr 1, 2026.
How has the price of MIDAZOLAM HCL 2 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for MIDAZOLAM HCL 2 MG/2 ML VIAL has risen 28.9%. It has been tracked across 81 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for MIDAZOLAM HCL 2 MG/2 ML VIAL?
Since Sep 18, 2024, the NADAC for MIDAZOLAM HCL 2 MG/2 ML VIAL has ranged from a low of $0.1862 (Sep 18, 2024) to a high of $0.2408 (Mar 11, 2026), with a median of $0.2086 per ML.
Are there cheaper alternatives to MIDAZOLAM HCL 2 MG/2 ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of MIDAZOLAM HCL 2 MG/2 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MIDAZOLAM HCL 2 MG/2 ML VIAL?
MIDAZOLAM HCL 2 MG/2 ML VIAL (NDC 72611074125) is labeled by Almaject, Inc., and CMS classifies it as a generic product.